| HIV-1 reverse transcriptase mutations found in a drug-experienced patient confer reduced susceptibility to multiple nucleoside reverse transcriptase inhibitors. |
Fitzgibbon JE, DiCola B, Arnold E, Das K, Sha BE, Pottage JC, Nahass R, Gaur S, John JF |
2001 |
| Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Loviride Collaborative Study Group. |
Staszewski S, Miller V, Kober A, Colebunders R, Vandercam B, Delescluse J, Clumeck N, Van Wanzeele F, De Brabander M, De Creé J, Moeremans M, Andries K, Boucher C, Stoffels P, Janssen PA |
1996 |
| Selection and characterization of HIV-1 variants resistant to the (+) and (-) enantiomers of 2'-deoxy-3'-oxa-4'-thiocytidine (dOTC). |
Richar N, Quan Y, Salomon H, Hsu M, Bedard J, Harrigan PR, Rando R, Mansour T, Bowlin TL, Wainberg MA |
1999 |
| Stavudine resistance: an update on susceptibility following prolonged therapy. |
Lin PF, González CJ, Griffith B, Friedland G, Calvez V, Ferchal F, Schinazi RF, Shepp DH, Ashraf AB, Wainberg MA, Soriano V, Mellors JW, Colonno RJ |
1999 |
| Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection. |
Wainberg MA, Sawyer JP, Montaner JS, Murphy RL, Kuritzkes DR, Raffi F |
2005 |
| Co-receptor usage and HIV-1 intra-clade C polymorphisms in the protease and reverse transcriptase genes of HIV-1 isolates from Ethiopia and Botswana. |
Loemba H, Brenner BG, Parniak MA, Ma'ayan S, Spira B, Moisi DD, Oliveira M, Detorio M, Essex M, Wainberg MA |
2002 |
| Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina. |
Kijak GH, Pampuro SE, Avila MM, Zala C, Cahn P, Wainberg MA, Salomón H |
2001 |
| Diminished HIV-1 sensitivity to stavudine in patients on prolonged therapy occurs only at low levels and cannot be attributed to any single amino acid substitution in reverse transcriptase. |
Salomon H, Montaner JS, Belmonte A, Wainberg MA |
1998 |
| Sensitivity and resistance to (+)-calanolide A of wild-type and mutated forms of HIV-1 reverse transcriptase. |
Quan Y, Motakis D, Buckheit R, Xu ZQ, Flavin MT, Parniak MA, Wainberg MA |
1999 |
| Resistance to (-)-2',3'-dideoxy-3'-thiacytidine (3TC) in HIV-1 isolated from paediatric patients. |
Wainberg MA, Lewis L, Salomon H, Gu Z, Keller A, Cammack N, Goldsmith J, Church J, Spira B, Wheeler S, Pizzo P |
1996 |
| Prevalence of genotypic resistance among antiretroviral drug-naive HIV-1-infected patients in Belgium. |
Van Vaerenbergh K, Debaisieux L, De Cabooter N, Declercq C, Desmet K, Fransen K, Maes B, Marissens D, Miller K, Muyldermans G, Sprecher S, Stuyver L, Vaira D, Verhofstede C, Zissis G, Van Ranst M, De Clercq E, Desmyter J, Vandamme AM |
2001 |